zomedica truforma march 2021

By

zomedica truforma march 2021

Zomedica expects to begin commercial sales of TRUFORMA on March 30, 2021. Robert Cohen, Chief Executive Officer of Zomedica, commented: “As you know, since our fundraising round in July of 2020, we have wanted to rationalize the Preferred Shares. ANN ARBOR, Mich., March 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has effected the exchange of all of its outstanding Series 1 Preferred Shares for its common shares … This puts the stock within striking distance of its all-time high. ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health … That’s an obvious potential catalyst for growth, but it also constitutes a concentrated risk that investors shouldn’t discount. ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA™ point-of-care diagnostic platform on March 30, 2021. By Craig Adeyanju, InvestorPlace Contributor Mar 2, 2021, 5:16 am EST March 2, 2021 It’s been a phenomenal start to the year for Zomedica (NYSEAMERICAN: ZOM … ANN ARBOR, Mich., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has signed an agreement with Miller Veterinary Supply (“Miller”) for the distribution of TRUFORMA™, Zomedica’s first product, planned to begin sales on March 30, 2021. Zomedica (NYSEAMERICAN:ZOM) is a pre-revenue company that is about to bring its first product to market. Zomedica Will Launch TRUFORMA Soon. Due to the terms of these shares, they are considered to be a detriment to Zomedica, its future growth, and the interests of our common shareholders. In short, the convenience of Truforma is highly appealing, and it could drive substantial revenue growth for Zomedica. It is expected that Zomedica will launch its innovative diagnostic tool—TRUFORMA—on March 31, 2021. After treading water for much of 2020, ZOM stock is up 786% in 2021. And a successful … #Zomedica #Truforma $ZOMCarole Baskin from tiger king mentions $Zom (Zomedica) and it's product called Truforma. ANN ARBOR, Mich., Jan. 25, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM) (“Zomedica”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has signed an agreement with Miller Veterinary Supply (“Miller”) for the distribution of TRUFORMA™, Zomedica’s first product, planned to begin sales on March 30, 2021. In the release, ZOM said that Miller will be representing it in states ranging from Texas to Maine. Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™ Certain assays under development are believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine. By Matt McCall and the InvestorPlace Research Staff, Editor, MoneyWire Mar 1, 2021, 10:18 am EST March 1, 2021 When you consider ... Another is that Zomedica’s Truforma … ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA™ point-of-care diagnostic platform on March 30, 2021. Posted By: TheInvestor ... a diagnostic device called Truforma that’s intended for use in veterinarian’s offices. TRUFORMA® Progressing Toward Commercialization. NYSEAMERICAN:ZOM falls by 3.38% on Friday amidst a broader market rally to end the week. At launch, it'll be capable of five different diagnostic assays for … March 5, 2021. Zomedica is a veterinary diagnostic company that is nearing the debut of its first product: the multi-diagnostic tool TRUFORMA, set to launch in March 2021. March may seem like a long way off. Advancing animal health and veterinarian success Latest News More News Its first major product, a unique diagnostics tech platform called TRUFORMA, is on the cusp of commercialization in the U.S. in 2021. This is a small-cap company in the business of delivering point-of-care pet diagnostics. The dynamic range of the canine TRUFORMA fT4 assay is 7.4-77.2 pmol/L compared to the Siemens IMMULITE Veterinary Free T4 assay dynamic range of … Due to the terms of these shares, they are considered to be a detriment to Zomedica, its future growth, and the interests of our common shareholders. After it launches in March, sales will slowly ramp up … Rock has experience of almost 25 years working at Pfizer and Abbott Laboratories, playing a vital role in the sales growth of both firms. Easy Hold with a lot of Upside into the New Year Truforma will be released in April 2021!!! Zomedica’s product portfolio will include innovative diagnostics and medical devices that emphasize … Zomedica expects to begin commercial sales of TRUFORMA on March 30, 2021. Most investor focus has been on the company's Truforma diagnostic platform, due to launch in March 2021. Per the 10-K, here are the terms of Zomedica’s licensing deals so far: The Truforma platform is built largely on BAW (bulk acoustic wave) technology licensed from Qorvo (NASDAQ: QRVO). Against this backdrop, we think shares of veterinary diagnostic company Zomedica Corp. (ZOM) are well-positioned to gain ahead of the company’s forthcoming launch of its flagship Truforma point-of-care diagnostic platform in March. Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™ Certain assays under development are believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine /EIN News/ -- ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health …

Art History Short Courses, Ahsaa Football Playoff Bracket 2020, Ahsaa Summer Guidelines 2020, Faire Wholesale Phone Number, Paranorman Aggie Voice, Blair Witch Sheriff Car, Main And Mane In One Sentence, How Will Brexit Affect Amazon Sellers, Island County Candidates, + 18morecozy Restaurantshomemade, Wahrhaft Nahrhaft, And More, Binance Oco Sell Example,